Works matching Cancer vaccines

Results: 5000
    1
    2
    3

    Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trial.

    Published in:
    Cancer Immunology, Immunotherapy, 2021, v. 70, n. 12, p. 3679, doi. 10.1007/s00262-021-03024-0
    By:
    • Filaci, Gilberto;
    • Fenoglio, Daniela;
    • Nolè, Franco;
    • Zanardi, Elisa;
    • Tomasello, Laura;
    • Aglietta, Massimo;
    • Del Conte, Gianluca;
    • Carles, Joan;
    • Morales-Barrera, Rafael;
    • Guglielmini, Pamela;
    • Scagliotti, Giorgio;
    • Signori, Alessio;
    • Parodi, Alessia;
    • Kalli, Francesca;
    • Astone, Giuseppina;
    • Ferrera, Francesca;
    • Altosole, Tiziana;
    • Lamperti, Giuseppina;
    • Criscuolo, Domenico;
    • Gianese, Francesco
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    WT1 epitope-specific IgG and IgM antibodies for immune-monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine.

    Published in:
    Oncology Letters, 2022, v. 23, n. 2, p. N.PAG, doi. 10.3892/ol.2022.13184
    By:
    • Alzaaqi, Shouq;
    • Naka, Norifumi;
    • Hamada, Kenichiro;
    • Hosen, Naoki;
    • Kanegae, Mizuki;
    • Outani, Hidetatsu;
    • Adachi, Mayuko;
    • Imanishi, Rin;
    • Morii, Eiichi;
    • Iwai, Miki;
    • Nakata, Jun;
    • Fujiki, Fumihiro;
    • Morimoto, Soyoko;
    • Nakajima, Hiroko;
    • Nishida, Sumiyuki;
    • Tsuboi, Akihiro;
    • Oka, Yoshihiro;
    • Sugiyama, Haruo;
    • Oji, Yusuke
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors.

    Published in:
    Cancer Immunology, Immunotherapy, 2020, v. 69, n. 4, p. 663, doi. 10.1007/s00262-020-02483-1
    By:
    • Ishihara, Mikiya;
    • Tono, Yasutaka;
    • Miyahara, Yoshihiro;
    • Muraoka, Daisuke;
    • Harada, Naozumi;
    • Kageyama, Shinichi;
    • Sasaki, Takeshi;
    • Hori, Yasuhide;
    • Soga, Norihito;
    • Uchida, Katsunori;
    • Shiraishi, Taizo;
    • Sato, Eiichi;
    • Kanda, Hideki;
    • Mizuno, Toshiro;
    • Webster, Gill A.;
    • Ikeda, Hiroaki;
    • Katayama, Naoyuki;
    • Sugimura, Yoshiki;
    • Shiku, Hiroshi
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Nucleic acid‐based vaccine for ovarian cancer cells; bench to bedside.

    Published in:
    Cell Biochemistry & Function, 2024, v. 42, n. 2, p. 1, doi. 10.1002/cbf.3978
    By:
    • Al‐Hawary, Sulieman Ibraheem Shelash;
    • Jasim, Saade Abdalkareem;
    • Hjazi, Ahmed;
    • Oghenemaro, Enwa Felix;
    • Kaur, Irwanjot;
    • Kumar, Abhinav;
    • Al‐Ani, Ahmed Muzahem;
    • Alwaily, Enas R.;
    • Redhee, Ahmed Huseen;
    • Mustafa, Yasser Fakri
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50